Identification of pleiotropic genes and biological mechanisms underlying the shared genetic component between asthma, neuropsychiatric disorders, and substance use behaviors
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Asthma patients suffer from neuropsychiatric disorders (NPDs) more often than expected and NPD patients have a higher prevalence of smoking, which can lead to asthma. To investigate the genetic mechanisms underlying this complex relationship, we performed an integrative analysis of GWAS summary statistics from four asthma subtypes, 12 NPDs, and six substance use behaviors (SUBs). Asthma shares an important genetic component with post-traumatic stress disorder (PTSD), major depressive disorder, and attention-deficit/hyperactivity disorder (ADHD) that cannot be fully accounted for by smoking. Multi-trait GWAS identified 354 independent variants mapping to 178 pleiotropic genes capturing the core of the shared genetics of asthma, NPD, and SUB. Single-cell transcriptomic analysis across blood, brain, and lung tissues revealed pleiotropic gene overexpression in 57 cell types and three candidate mechanisms linking asthma and NPDs. First, immune-related pleiotropic genes are expressed in microglia, blood and lung immune cells, suggesting shared immune dysfunction. Second, the pleiotropic genes EP300 , RERE , and MAML3 regulate NOTCH signaling and are expressed in neurons, microglia, and lymphoid progenitors. Third, pleiotropic genes expressed in ciliated cells of both lung and brain implicate ciliary dysfunction. These findings may help identify new treatment strategies for patients with co-occurring asthma and neuropsychiatric disorders.
